2021). Li et al. showed that miR-1224-5p was able to attenuate the symptoms of PCOS mice through inhibiting the activation of NLRP3 inflammasome via targeting FOXO1 (Li et al. 2021). Here, FOXO1 is linked to polycystic ovary syndrome.